355 related articles for article (PubMed ID: 29500217)
21. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM
Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354
[TBL] [Abstract][Full Text] [Related]
22. Use of metformin to control clozapine-associated weight gain in an adolescent with schizoaffective disorder.
Weaver LA; De León DD; Borgmann-Winter K; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):153-7. PubMed ID: 20415612
[No Abstract] [Full Text] [Related]
23. Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.
Fleischhacker WW; Heikkinen ME; Olié JP; Landsberg W; Dewaele P; McQuade RD; Loze JY; Hennicken D; Kerselaers W
Int J Neuropsychopharmacol; 2010 Sep; 13(8):1115-25. PubMed ID: 20459883
[TBL] [Abstract][Full Text] [Related]
24. Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.
Out M; Miedema I; Jager-Wittenaar H; van der Schans C; Krijnen W; Lehert P; Stehouwer C; Kooy A
Diabetes Obes Metab; 2018 Jan; 20(1):219-223. PubMed ID: 28681986
[TBL] [Abstract][Full Text] [Related]
25. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
Miller LJ
Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
[TBL] [Abstract][Full Text] [Related]
26. The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.
Khan AY; Macaluso M; McHale RJ; Dahmen MM; Girrens K; Ali F
J Psychiatr Pract; 2010 Sep; 16(5):289-96. PubMed ID: 20859106
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents.
Arman S; Sadramely MR; Nadi M; Koleini N
Saudi Med J; 2008 Aug; 29(8):1130-4. PubMed ID: 18690305
[TBL] [Abstract][Full Text] [Related]
28. Metformin for the prevention of clozapine-induced weight gain: A retrospective naturalistic cohort study.
Stogios N; Maksyutynska K; Navagnanavel J; Sanches M; Powell V; Gerretsen P; Graff-Guerrero A; Chintoh AF; Foussias G; Remington G; Hahn MK; Agarwal SM
Acta Psychiatr Scand; 2022 Sep; 146(3):190-200. PubMed ID: 35726126
[TBL] [Abstract][Full Text] [Related]
29. A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome.
Zimbron J; Khandaker GM; Toschi C; Jones PB; Fernandez-Egea E
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1353-1365. PubMed ID: 27496573
[TBL] [Abstract][Full Text] [Related]
30. Topiramate's effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial.
Chandradasa M; Champika L; de Silva S; Kuruppuarachchi KALA
Trials; 2017 Sep; 18(1):435. PubMed ID: 28931411
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Ellinger LK; Ipema HJ; Stachnik JM
Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
[TBL] [Abstract][Full Text] [Related]
32. Gaining: pediatric patients and use of atypical antipsychotics.
Towbin KE
Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
[No Abstract] [Full Text] [Related]
33. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
[TBL] [Abstract][Full Text] [Related]
34. Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies.
Bushe CJ; Bradley AJ; Doshi S; Karagianis J
Int J Clin Pract; 2009 Dec; 63(12):1743-61. PubMed ID: 19840151
[TBL] [Abstract][Full Text] [Related]
35. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.
Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P
J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584
[TBL] [Abstract][Full Text] [Related]
36. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.
Anagnostou E; Aman MG; Handen BL; Sanders KB; Shui A; Hollway JA; Brian J; Arnold LE; Capano L; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Hadjiyannakis S; Peleg N; Odrobina D; McAuliffe-Bellin S; Zakroysky P; Marler S; Wagner A; Wong T; Macklin EA; Veenstra-VanderWeele J
JAMA Psychiatry; 2016 Sep; 73(9):928-37. PubMed ID: 27556593
[TBL] [Abstract][Full Text] [Related]
37. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
38. The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.
Ghanizadeh A; Nikseresht MS; Sahraian A
Schizophr Res; 2013 Jun; 147(1):110-115. PubMed ID: 23583010
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program.
Wu MK; Wang CK; Bai YM; Huang CY; Lee SD
Psychiatr Serv; 2007 Apr; 58(4):544-50. PubMed ID: 17412858
[TBL] [Abstract][Full Text] [Related]
40. Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study.
Spokes J; Hollingworth S; Winckel K; Kisely S; Baker A; Cosgrove P; Siskind D
Ther Adv Psychopharmacol; 2021; 11():20451253211000609. PubMed ID: 33796266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
